Skip to content
10-Q

Quarterly Report

RESPIRERX PHARMACEUTICALS INC.

0001493152-23-029607

← back to feed
Filed
Aug 21, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 18, 2023 275.73M sh
Shares Diluted Q2 2023 · Jun 30, 2023 168.21M sh
Shares Diluted Q2 2023 · Jun 30, 2023 158.4M sh
Shares Diluted Q2 2023 · Jun 30, 2022 106.08M sh
Shares Diluted Q2 2023 · Jun 30, 2022 102.01M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$157.77K
Operating Cash Flow Q2 2023 · Dec 31, 2022 −$143.91K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$85.12K
Cash And Equivalents Q2 2023 · Jun 30, 2023 $7.32K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $88
Stockholders Equity Q2 2023 · Jun 30, 2023 −$12.14M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$12.31M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$11.88M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$11.13M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$10.87M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$10.01M
Current Liabilities Q2 2023 · Jun 30, 2023 $12.21M
Current Liabilities Q2 2023 · Dec 31, 2022 $11.73M
Total Liabilities Q2 2023 · Jun 30, 2023 $12.28M
Total Liabilities Q2 2023 · Dec 31, 2022 $11.9M
Current Assets Q2 2023 · Jun 30, 2023 $141.28K
Current Assets Q2 2023 · Dec 31, 2022 $22.78K
Total Assets Q2 2023 · Jun 30, 2023 $141.28K
Total Assets Q2 2023 · Dec 31, 2022 $22.78K
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.00
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.02
Eps Basic Q2 2023 · Jun 30, 2023 −$0.00
Eps Basic Q2 2023 · Jun 30, 2023 −$0.01
Eps Basic restated Q2 2023 · Jun 30, 2022 −$0.01
Eps Basic restated Q2 2023 · Jun 30, 2022 −$0.02
Sga Expense Q2 2023 · Jun 30, 2023 $367.64K
Sga Expense Q2 2023 · Jun 30, 2023 $659.56K
Sga Expense Q2 2023 · Jun 30, 2022 $211.38K
Sga Expense Q2 2023 · Jun 30, 2022 $707.17K
Rd Expense Q2 2023 · Jun 30, 2023 $98.22K
Rd Expense Q2 2023 · Jun 30, 2023 $196.64K
Rd Expense Q2 2023 · Jun 30, 2022 $141.1K
Rd Expense Q2 2023 · Jun 30, 2022 $262.26K
Net Income Q2 2023 · Jun 30, 2023 −$681.03K
Net Income Q2 2023 · Jun 30, 2023 −$1.11M
Net Income Q2 2023 · Mar 31, 2023 −$430.06K
Net Income Q2 2023 · Jun 30, 2022 −$480.29K
Net Income Q2 2023 · Jun 30, 2022 −$1.34M
Net Income Q2 2023 · Mar 31, 2022 −$860.16K
Operating Income Q2 2023 · Jun 30, 2023 −$465.86K
Operating Income Q2 2023 · Jun 30, 2023 −$856.2K
Operating Income Q2 2023 · Jun 30, 2022 −$352.48K
Operating Income Q2 2023 · Jun 30, 2022 −$969.43K